James Sutton

4.6k total citations · 2 hit papers
24 papers, 3.1k citations indexed

About

James Sutton is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, James Sutton has authored 24 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in James Sutton's work include Chemical Synthesis and Analysis (6 papers), Synthesis and Catalytic Reactions (5 papers) and Synthesis of β-Lactam Compounds (4 papers). James Sutton is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Synthesis and Catalytic Reactions (5 papers) and Synthesis of β-Lactam Compounds (4 papers). James Sutton collaborates with scholars based in United States, Germany and Switzerland. James Sutton's co-authors include Daniela F. Quail, Marsha L. Quick, Robert L. Bowman, Johanna A. Joyce, Leila Akkari, Alberto J. Schuhmacher, Eric C. Holland, Jason T. Huse, Dylan Daniel and Yoko Oei and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

James Sutton

24 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

2013 1.8k citations Stephanie M. Pyonteck, Leila Akkari et al. Nature Medicine profile →
The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

2016 519 citations Daniela F. Quail, Robert L. Bowman et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Sutton United States	16	1.9k	1.0k	902	666	544	24	3.1k
Neill A. Giese United States	26	741 0.4×	650 0.6×	2.2k 2.5×	1.8k 2.6×	224 0.4×	43	4.5k
Paul Mulholland United Kingdom	24	679 0.4×	853 0.8×	736 0.8×	1.3k 1.9×	117 0.2×	48	2.7k
Sophia B. Chernikova United States	15	484 0.3×	416 0.4×	878 1.0×	397 0.6×	207 0.4×	23	1.5k
Elena Levantini United States	22	1.0k 0.5×	785 0.8×	1.6k 1.8×	171 0.3×	61 0.1×	48	3.0k
Tsipi Meshel Israel	28	1.1k 0.6×	1.5k 1.5×	939 1.0×	147 0.2×	92 0.2×	63	2.6k
Badarch Uranchimeg United States	14	486 0.3×	666 0.6×	1.2k 1.3×	156 0.2×	78 0.1×	17	2.2k
Rosaria Gangemi Italy	25	485 0.3×	760 0.7×	1.1k 1.2×	199 0.3×	29 0.1×	52	2.2k
Carsten Hagemann Germany	26	237 0.1×	404 0.4×	1.1k 1.2×	320 0.5×	74 0.1×	74	2.0k
Tse‐Ming Hong Taiwan	33	741 0.4×	993 1.0×	2.2k 2.4×	62 0.1×	114 0.2×	65	3.3k
Xiaoguang Fang United States	22	723 0.4×	1.1k 1.1×	2.0k 2.3×	794 1.2×	245 0.5×	22	3.4k

Countries citing papers authored by James Sutton

Since Specialization

Citations

This map shows the geographic impact of James Sutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Sutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Sutton more than expected).

Fields of papers citing papers by James Sutton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Sutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Sutton. The network helps show where James Sutton may publish in the future.

Co-authorship network of co-authors of James Sutton

This figure shows the co-authorship network connecting the top 25 collaborators of James Sutton. A scholar is included among the top collaborators of James Sutton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Sutton. James Sutton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chhatbar, Chintan, Claudia N. Detje, Elena Grabski, et al.. (2018). Type I Interferon Receptor Signaling of Neurons and Astrocytes Regulates Microglia Activation during Viral Encephalitis. Cell Reports. 25(1). 118–129.e4. 83 indexed citations

Beffinger, Michał, Paulino Tallón de Lara, Sònia Tugues, et al.. (2018). CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis. JCI Insight. 3(10). 37 indexed citations

Martin, Leenus, Tzuling Cheng, Dominic I. James, et al.. (2018). Abstract 1943: PARG inhibitors exhibit synthetic lethality with XRCC1 deficiency and a cellular mechanism of action that is distinct from PARP inhibition. Cancer Research. 78(13_Supplement). 1943–1943. 4 indexed citations

Quail, Daniela F., Robert L. Bowman, Leila Akkari, et al.. (2016). The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas. Science. 352(6288). aad3018–aad3018. 519 indexed citations breakdown →

Mitra, Partha, et al.. (2016). CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition ofMYBandMCL-1expression. Oncotarget. 7(8). 9069–9083. 38 indexed citations

Xie, Lili, Charles Wartchow, Steven Shia, et al.. (2015). Molecular Basis of mRNA Cap Recognition by Influenza B Polymerase PB2 Subunit. Journal of Biological Chemistry. 291(1). 363–370. 19 indexed citations

Akkari, Leila, Daniela F. Quail, Marsha L. Quick, et al.. (2015). Abstract A33: Combinatorial targeting of tumor-associated macrophages/ microglia and radiotherapy in gliomas. Cancer Research. 75(23_Supplement). A33–A33. 1 indexed citations

Krauser, Joel A., Yi Jin, Markus Walles, et al.. (2014). Phenotypic and metabolic investigation of a CSF-1R kinase receptor inhibitor (BLZ945) and its pharmacologically active metabolite. Xenobiotica. 45(2). 107–123. 29 indexed citations

Sutton, James, Gregory S. Bisacchi, Bruce L. Jacobson, et al.. (2013). Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffold. Bioorganic & Medicinal Chemistry Letters. 23(18). 5239–5243. 12 indexed citations

10.

Pyonteck, Stephanie M., Leila Akkari, Alberto J. Schuhmacher, et al.. (2013). CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nature Medicine. 19(10). 1264–1272. 1799 indexed citations breakdown →

11.

Pi, Zulan, James Sutton, John Lloyd, et al.. (2013). 2-Aminothiazole based P2Y1 antagonists as novel antiplatelet agents. Bioorganic & Medicinal Chemistry Letters. 23(14). 4206–4209. 16 indexed citations

12.

Shi, Shuhao, Shirong Zhu, Samuel W. Gerritz, et al.. (2009). Solid-phase synthesis of a library based on biphenyl-containing trypsin-like serine protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(22). 6477–6480. 3 indexed citations

13.

Bi, Yingzhi, Alexandra A. Nirschl, James Sutton, et al.. (2007). Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators. Bioorganic & Medicinal Chemistry Letters. 17(16). 4487–4490. 18 indexed citations

14.

Bisacchi, Gregory S., Philip D. Stein, Jack Z. Gougoutas, et al.. (2005). Initial Structure-Activity Relationships for a Caprolactam-based Series of Neutral Factor Xa Inhibitors: Lead Identification. Letters in Drug Design & Discovery. 2(8). 625–630. 7 indexed citations

15.

Bisacchi, Gregory S., William A. Slusarchyk, Karen S. Hartl, et al.. (2004). Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase. Bioorganic & Medicinal Chemistry Letters. 14(9). 2227–2231. 27 indexed citations

16.

Sutton, James, Malcolm E. Davis, Karen S. Hartl, et al.. (2004). Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(9). 2233–2239. 56 indexed citations

17.

Zhao, Guohua, Chet Kwon, Karen S. Hartl, et al.. (2003). Synthesis of potent and selective 2-azepanone inhibitors of human tryptase. Bioorganic & Medicinal Chemistry Letters. 14(2). 309–312. 14 indexed citations

18.

Slusarchyk, William A., Karen S. Hartl, Ming‐Hsing Huang, et al.. (2002). Synthesis of potent and highly selective inhibitors of human tryptase. Bioorganic & Medicinal Chemistry Letters. 12(21). 3235–3238. 41 indexed citations

19.

Sutton, James, Karen S. Hartl, Ming‐Hsing Huang, et al.. (2002). Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(21). 3229–3233. 53 indexed citations

20.

Wender, Paul A., Paul E. Floreancig, Timothy E. Glass, et al.. (1995). Toward the synthesis of taxol and its analogs: Incorporation of non-aromatic C-rings in the pinene pathway. Tetrahedron Letters. 36(28). 4939–4942. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact